alexa Abstract | Effects of Celecoxib or Omega-3 Fatty Acids Alone and in Combination with Risperidone on the Behavior and Brain Biochemistry Using Amphetamine-Induced Model of Schizophrenia in Rats

Journal of Pharmacological Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Study background: The implication of oxidative stress and neuro-inflammation in the pathogenesis of schizophrenia has been elucidated. Antipsychotics have limited effectiveness against negative symptoms of schizophrenia and are associated with adverse effects. The use of celecoxib or omega-3 in schizophrenia may have beneficial effects. This study was to evaluate the possible efficacies of celecoxib, omega-3 or the combination of celecoxib+risperidone and omeg-3+risperidone compared to risperidone on behavior and brain biochemistry in rats. Method: An amphetamine-induced model of schizophrenia in adult male rats was used to evaluate the effects of celecoxib, omega-3, celecoxib+risperidone and omega-3+risperidone on the behavior of animals and on brain lipid peroxidation or tumor necrosis factor-alpha. Results In the water maze task, celecoxib, omega-3, celecoxib+risperidone, omega-3+risperidone significantly decreased the latency time and increased the swimming speeds compared to amphetamine-treated group. celecoxib, omega-3, celecoxib+risperidone, omega-3+risperidone also significantly reversed the decreased spontaneous alternation induced by amphetamine in the Y-maze task. In the social interaction task, groups treated with celecoxib, omega-3, celecoxib+risperidone, omega-3+risperidone spent less time to recognize foreign animals than animals in the amphetamine-treated group. Increased brain MDA and TNF-α level due to amphetamine were significantly reduced in groups treated with celecoxib+risperidone or omega-3+risperidone. Conclusion: Celecoxib or omega-3 can attenuate amphetamine- induced behavioral impairment. These effects may be associated with their ability to decrease lipid peroxidation and cytokine release. Celecoxib or omega-3 may be promising candidates for treating such disease.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Enass Yossef Osman



Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version